Procter & Gamble CEO Shailesh Jejurikar Awarded Stock Options for 22,787 Shares
PROCTER & GAMBLE Co
Subscribe to track PG
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
PROCTER & GAMBLE CO ($PG) Form 4 Filing
Insider: Shailesh Jejurikar (Chairman, President and CEO)
Transaction: Option Grant (Code A)
Security: Stock Option (Right to Buy)
Shares: 22,787 @ Exercise Price $146.67
Value: $0.00 (Award)
Date: 2026-09-15
Direct Holdings Post-Filing: 39,325.9973 common shares | 22,787 options
Comprehensive Analysis
Executive Compensation Option Grant Analysis
Overview: On September 17, 2026, Procter & Gamble Co ($PG) filed a Form 4 reporting an equity compensation grant to Chairman, President, and CEO Shailesh Jejurikar. On September 15, 2026, Mr. Jejurikar received employee stock options covering 22,787 shares of common stock under an issuer incentive plan.
Transaction Details:
- Security: Stock Option (Right to Buy Common Stock)
- Transaction Code:
A(Grant, award, or other acquisition pursuant to Rule 16b-3(d)) - Number of Underlying Shares: 22,787
- Exercise Price: $146.67 per share
- Vesting / Exercise Date: September 14, 2029
- Expiration Date: September 15, 2036
- Acquisition Cost: $0.00
Holdings Breakdown: Following the award, Mr. Jejurikar holds:
- Direct Common Stock: 39,325.9973 shares
- Indirect Common Stock:
- 3,741.7415 shares via Retirement Plan Trustee
- 19,757 shares via Sankhya S Jejurikar Revocable Trust
- 35,836 shares via Shailesh Jejurikar Trust
- Derivative Holdings: 22,787 options from this grant
Significance: This transaction represents routine annual executive equity compensation and does not involve open-market buying or selling. As such, the market significance is Low.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.